Altimmune (ALT) Shares Outstanding (2010 - 2026)

Altimmune (ALT) has 9 years of Shares Outstanding (Entity) data on file, last reported at $2.8 million in Q4 2018.

• On a quarterly basis, Shares Outstanding (Entity) rose 556.61% year-over-year to $2.8 million in Q4 2018; TTM through Dec 2018 was $2.8 million, a 556.61% increase from a year earlier, with the FY2018 full-year figure at $2.8 million, up 556.61% from the prior year.
• Shares Outstanding (Entity) for Q4 2018 stood at $2.8 million, up from $1.3 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for ALT reached as high as $2.8 million in Q4 2018 and fell as low as $179228.0 in Q1 2014.
• Historically, Shares Outstanding (Entity) has averaged $496130.2 across 5 years, with a median of $218659.5 in 2016.
• Across the five-year window, Shares Outstanding (Entity) gained 1.21% in 2016 and soared 556.61% in 2018, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $211990.0 in 2014, then grew by 1.22% to $214585.0 in 2015, then rose by 5.19% to $225732.0 in 2016, then jumped by 89.07% to $426794.0 in 2017, then surged by 556.61% to $2.8 million in 2018.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $2.8 million in Q4 2018, $1.3 million in Q3 2018, and $950919.0 in Q2 2018.